Protagonist Therapeutics, Inc. (PTGX)
154.70
+0.38
(+0.25%)
USD |
NASDAQ |
Aug 24, 16:00
154.70
0.00 (0.00%)
After-Hours: 20:00
Protagonist Therapeutics Market Cap : 10.00B for Aug. 24, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Market Cap Data
| Date | Value |
|---|---|
| August 21, 2026 | 9.980B |
| August 20, 2026 | 9.745B |
| August 19, 2026 | 10.02B |
| August 18, 2026 | 10.18B |
| August 17, 2026 | 10.26B |
| August 14, 2026 | 10.03B |
| August 13, 2026 | 9.793B |
| August 12, 2026 | 9.831B |
| August 11, 2026 | 9.590B |
| August 10, 2026 | 9.701B |
| August 07, 2026 | 9.434B |
| August 06, 2026 | 9.454B |
| August 05, 2026 | 8.881B |
| August 04, 2026 | 8.783B |
| August 03, 2026 | 8.496B |
| July 31, 2026 | 8.776B |
| July 30, 2026 | 8.904B |
| July 29, 2026 | 8.542B |
| July 28, 2026 | 8.789B |
| July 27, 2026 | 8.707B |
| July 24, 2026 | 8.742B |
| July 23, 2026 | 8.698B |
| July 22, 2026 | 8.699B |
| July 21, 2026 | 8.883B |
| July 20, 2026 | 8.624B |
| Date | Value |
|---|---|
| July 17, 2026 | 9.050B |
| July 16, 2026 | 8.479B |
| July 15, 2026 | 8.700B |
| July 14, 2026 | 8.431B |
| July 13, 2026 | 8.342B |
| July 10, 2026 | 8.441B |
| July 09, 2026 | 8.840B |
| July 08, 2026 | 8.996B |
| July 07, 2026 | 9.046B |
| July 06, 2026 | 8.446B |
| July 02, 2026 | 8.454B |
| July 01, 2026 | 8.039B |
| June 30, 2026 | 7.873B |
| June 29, 2026 | 7.812B |
| June 26, 2026 | 7.828B |
| June 25, 2026 | 7.876B |
| June 24, 2026 | 7.845B |
| June 23, 2026 | 7.640B |
| June 22, 2026 | 7.388B |
| June 18, 2026 | 7.249B |
| June 17, 2026 | 7.157B |
| June 16, 2026 | 7.106B |
| June 15, 2026 | 7.223B |
| June 12, 2026 | 7.051B |
| June 11, 2026 | 7.051B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Gilead Sciences, Inc. | 182.13B |
| Insmed, Inc. | 27.07B |
| Madrigal Pharmaceuticals, Inc. | 11.82B |
| AbbVie, Inc. | 467.37B |
| PTC Therapeutics, Inc. | 5.918B |
Market Cap Related Metrics
| PE Ratio | 149.18 |
| PS Ratio | 36.93 |
| PEG Ratio | 3.276 |
| Price to Book Value | 11.89 |
| Price to Free Cash Flow | 79.76 |
| Price | 154.70 |
| Earnings Yield | 0.67% |
| PEGY Ratio | 3.276 |
| Operating PE Ratio | 178.52 |
| Normalized PE Ratio | 149.17 |